TriSalus Life Sciences, Inc. Logo

TriSalus Life Sciences, Inc.

Oncology company integrating drug delivery with immunotherapy to treat solid tumors.

TLSI | US

Overview

Corporate Details

ISIN(s):
US58507N2045 (+2 more)
LEI:
Country:
United States of America
Address:
6272 WEST 91ST AVENUE, 80031 WESTMINSTER

Description

TriSalus Life Sciences is an oncology company focused on developing treatments for solid tumors, particularly in the liver and pancreas. The company's therapeutic platform integrates its proprietary Pressure-Enabled Drug Delivery™ (PEDD™) technology with investigational immunotherapies. This integrated approach is designed to overcome critical barriers to treatment, such as high intratumoral pressure and the immunosuppressive tumor microenvironment, which can limit the efficacy of cancer therapies. Key components of its platform include the TriNav® Infusion System for targeted drug delivery and the investigational immunotherapy candidate, nelitolimod. The company aims to improve patient outcomes by enhancing the delivery and effectiveness of treatments, often in combination with systemic immunotherapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all TriSalus Life Sciences, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TriSalus Life Sciences, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TriSalus Life Sciences, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.